Relievant Medsystems, Inc.

Sunnyvale,  CA 
United States
  • Booth: 2355, 2749

Relievant Medsystems welcomes you to NASS 2018.

Relievant Medsystems is a medical device company focused on solutions for treating chronic low back pain (CLBP).  Relievant developed the Intracept Procedure – a minimally invasive procedure targeting the basivertebral nerve for the relief of CLBP.  The basivertebral nerve (BVN) is an intraosseous nerve within the vertebral body.   The BVN is a pain sensing nerve that innervates the vertebral body endplates and is a source of CLBP associated with degenerated endplates.

Relievant sponsored the SMART Trial - a Level 1, prospective, randomized, double-blinded, sham-controlled clinical trial evaluating pain reduction in subjects with CLBP.  The Trial enrolled 225 patients to evaluate the safety and effectiveness of the Intracept System for the treatment of CLBP.

The Intracept System is FDA 510(k) cleared and commercially available in the US.

Learn more at

Brands: Intracept, Relievant, Intraosseous Nerve Ablation System, nerve ablation, radiofrequency, chronic low back pain, modic changes, minimally invasive, basivertebral nerve, CLBP, BVN, RF, LBP, SMART Study